Literature DB >> 24920467

Comparison of the effects of clonidine, loperamide and metoclopramide in two models of gastric emptying in the rat.

Sonia Goineau1, Philippe Guillaume, Vincent Castagné.   

Abstract

Several methods are used to evaluate gastric emptying (GE) in rats, which is an important endpoint in preclinical drug development. Although phenol red model or monitoring of plasma acetaminophen levels are well-established procedures for GE assessment, their capacity to detect the effects of pharmacological agents has rarely been compared. This study was therefore designed to evaluate clonidine with loperamide and metoclopramide in the two test models. Rats were administered phenol red or acetaminophen test meals. The remaining amount of phenol red in the stomach or the time course of plasma acetaminophen levels was then measured. In the phenol red test, loperamide (8 mg/kg, p.o.) and clonidine (100 μg/kg, s.c.) decreased GE (-88 and -42%, P < 0.001 and P < 0.01, respectively). Metoclopramide (10 mg/kg, s.c.) accelerated GE (+42%, P < 0.01). Loperamide reduced acetaminophen plasma levels (-45% at T15 min, P < 0.05), suggesting a delayed GE. Clonidine and metoclopramide increased acetaminophen plasma levels (+115 and +152% at T15 min, P < 0.05 and P < 0.001, respectively), suggesting an accelerated GE. The three substances did not affect plasma acetaminophen levels when acetaminophen was subcutaneously injected, thereby suggesting that acetaminophen metabolism/excretion was not modified. Whereas the phenol red test allows the evaluation of GE at a single time point, the measurement of plasma acetaminophen levels over the time would appear more informative. Nevertheless, the fact that clonidine, in contrast to expectation, increased plasma acetaminophen levels, suggests that data obtained with the acetaminophen method should be interpreted with caution for new chemical entities susceptible to modify absorption of acetaminophen from the small intestine.
© 2014 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  acetaminophen; clonidine; gastric emptying; loperamide; metoclopramide; phenol red

Mesh:

Substances:

Year:  2014        PMID: 24920467     DOI: 10.1111/fcp.12086

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  6 in total

1.  Metoclopramide role in preventing ileus after cesarean, a clinical trial.

Authors:  Jila Agah; Roya Baghani; Mohammad Hassan Rakhshani; Abolfazl Rad
Journal:  Eur J Clin Pharmacol       Date:  2015-04-15       Impact factor: 2.953

2.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

3.  The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.

Authors:  Eun Jeong Jeong; Soo Yong Chung; Han Na Hong; Se-Woong Oh; Jae Young Sim
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

4.  Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.

Authors:  Onur Cil; Marc O Anderson; Robert Yen; Bryan Kelleher; Tony L Huynh; Youngho Seo; Steven P Nilsen; Jerrold R Turner; Alan S Verkman
Journal:  FASEB J       Date:  2019-07-12       Impact factor: 5.834

5.  Electroacupuncture at ST36 Improve the Gastric Motility by Affecting Neurotransmitters in the Enteric Nervous System in Type 2 Diabetic Rats.

Authors:  Xu Han; Xiaoyan Chen; Xuan Wang; Meirong Gong; Mengjiang Lu; Zhi Yu; Bin Xu; Jinhong Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

6.  MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.

Authors:  Dong Xu; Alexandrea G Ham; Rickey D Tivis; Matthew L Caylor; Aoxiang Tao; Steve T Flynn; Peter J Economen; Hung K Dang; Royal W Johnson; Vaughn L Culbertson
Journal:  EBioMedicine       Date:  2017-11-22       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.